GlucoModicum Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 49

Employees

  • Latest Deal Type
  • Early Stage VC
  • (Cancelled)

  • Investors
  • 14

GlucoModicum General Information

Description

Developer of non-invasive glucose monitoring technology designed to provide continuous glucose measurement without the use of needles. The company's platform is based on magnetohydrodynamic technology that samples interstitial fluid through the skin rapidly and gently, enabling individuals with diabetes and healthcare providers to monitor glucose levels, supporting management of blood glucose without the discomfort associated with traditional methods.

Contact Information

Website
www.glucomodicum.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Toinen Linja 7
  • 6 Kerros
  • 00530 Helsinki
  • Finland
Primary Industry
Monitoring Equipment
Vertical(s)
Digital Health, Wearables & Quantified Self, HealthTech
Corporate Office
  • Toinen Linja 7
  • 6 Kerros
  • 00530 Helsinki
  • Finland

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

GlucoModicum Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Early Stage VC Cancelled Generating Revenue
9. Grant 01-Dec-2022 Completed Generating Revenue
8. Grant 16-Jun-2021 Completed Generating Revenue
7. Early Stage VC 29-Oct-2021 Completed Generating Revenue
6. Accelerator/Incubator 14-Oct-2021 Completed Generating Revenue
5. Early Stage VC (Series B) 04-Dec-2020 Completed Generating Revenue
4. Seed Round 31-May-2019 Completed Generating Revenue
3. Seed Round 13-Sep-2018 Completed Startup
2. Seed Round 15-Apr-2018 $616K $616K Completed Startup
1. University Spin-Out 01-Jan-2018 Completed Startup
To view GlucoModicum’s complete valuation and funding history, request access »

GlucoModicum Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series B
Series B
Ordinary 12,218 $71.18 $71.18 1x $71.18 7.18%
Ordinary 16,666 $34.8 $34.8 1x $34.8 9.8%
To view GlucoModicum’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

GlucoModicum Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

GlucoModicum Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds
European Investment Bank Investment Bank Minority
European Union Government Minority
Proxy Ventures Venture Capital Minority
European Commission Government
European Innovation Council Accelerator/Incubator Minority
You’re viewing 5 of 14 investors. Get the full list »

Ready to get started?

Request a free trial

GlucoModicum FAQs

  • When was GlucoModicum founded?

    GlucoModicum was founded in 2018.

  • Where is GlucoModicum headquartered?

    GlucoModicum is headquartered in Helsinki, Finland.

  • What is the size of GlucoModicum?

    GlucoModicum has 49 total employees.

  • What industry is GlucoModicum in?

    GlucoModicum’s primary industry is Monitoring Equipment.

  • Is GlucoModicum a private or public company?

    GlucoModicum is a Private company.

  • What is GlucoModicum’s current revenue?

    The current revenue for GlucoModicum is .

  • How much funding has GlucoModicum raised over time?

    GlucoModicum has raised $33.5M.

  • Who are GlucoModicum’s investors?

    European Investment Bank, European Union, Proxy Ventures, European Commission, and European Innovation Council are 5 of 14 investors who have invested in GlucoModicum.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process